Home › Geographic Atrophy › Oregon › Eugene
Geographic Atrophy clinical trials in Eugene, OR
3 studies for Geographic Atrophy are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
RecruitingPhase 1/2
- Oregon Retina- Site Number : 8400017, Eugene
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Verum Research LLC, Eugene
- Cascade Medical Research Institute LLC, Springfield · 3 mi away
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Verum Research LLC, Eugene
- Cascade Medical Research Institute, LLC, Springfield · 3 mi away
Geographic Atrophy trials in other cities
- Dallas, TX8 studies
- Reno, NV8 studies
- Santa Monica, CA7 studies
- Austin, TX7 studies
- Houston, TX6 studies
- Naperville, IL6 studies
- Cleveland, OH6 studies
- The Woodlands, TX6 studies
- Baltimore, MD6 studies
- Hagerstown, MD5 studies
- Erie, PA5 studies
- San Antonio, TX5 studies
Other studies in Eugene
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Endometrial Cancer8 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Multiple Myeloma6 studies
- Lung Cancer5 studies
- Drug Use and Addiction5 studies
- Macular Degeneration5 studies
- Obesity4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.